How I use laboratory monitoring of antiplatelet therapy.
Alan D MichelsonDeepak L BhattPublished in: Blood (2017)
Antiplatelet therapy is of proven benefit in coronary artery disease and a number of other clinical settings. This article reviews platelet function, molecular targets of antiplatelet agents, and clinical indications for antiplatelet therapy before focusing on a frequent question to hematologists about the 2 most commonly used antiplatelet therapies: Could the patient be aspirin "resistant" or clopidogrel "resistant"? If so, should results of a platelet function test be used to guide the dose or type of antiplatelet therapy? Whether such guided therapy is of clinical benefit to patients has been a source of controversy. The present article reviews this subject in the context of 2 prototypical clinical cases. Available evidence does not support the use of laboratory tests to guide the dose of aspirin or clopidogrel in patients with so-called aspirin or clopidogrel "resistance."
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- coronary artery disease
- end stage renal disease
- low dose
- stem cells
- heart failure
- ejection fraction
- chronic kidney disease
- newly diagnosed
- cardiovascular disease
- peritoneal dialysis
- cardiovascular events
- prognostic factors
- systematic review
- aortic stenosis
- bone marrow